The United Kingdom is turning children into test experiments. When the government announced last year that it would ban the prescription of puberty blockers to minors, it seemed to mark a decisive turn: The country had absorbed the hard lessons spelled out in the Cass Review, an independent analysis of the consequences of transgender ideology for minors. The review was a turning point — not just for Britain, but for countries worldwide seeking to move away from the ideological capture wrought by transgender experimentation.
Unfortunately, following the Cass Review’s recommendation that any use of puberty blockers be confined to research, the National Health Service commissioned a major clinical trial. Known as PATHWAYS (Puberty Suppression and Transitional Healthcare with Adaptive Youth Services), the trial is now set to commence, involving around 220 children under the age of 16, including kids as young as ten. These young children will be subjected to dangerous puberty blockers in the name of “research.”
Comments